During the COVID-19 pandemic, the number of patients admitted to hospitals for clinical depression care dropped significantly. However, the number of people seeking out-patient care for depression increased.
Researchers use CRISPR gene editing technology to target GABA receptors in order to help treat mood disorders.
A new study reports those who suffer from persistent depression lasting more than ten years have higher levels of neuroinflammation.
According to a new study, clinically depressed children show a blunted response to reward compared to those who were not depressed.
A new study reports teenage boys with raised cortisol levels and depressive symptoms are up to 14 times more likely to develop major depression that their peers.
